Skip to content

Liposuction as Treatment for Excessive Axillary Sweat

Suction-Curettage vs. Standard Excision in Axillary Hyperhidrosis

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00228072
Enrollment
50
Registered
2005-09-28
Start date
Unknown
Completion date
Unknown
Last updated
2008-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperhidrosis

Keywords

Hyperhidrosis, Axillary, Excision, Suction-curettage, Outcome

Brief summary

The purpose of this study is to determine if suction-curettage of the axilla is favorable in regard to effect, recovery and cosmetic appearance compared to standard surgical excision of the skin of the axilla in case of excessive sweating.

Detailed description

The surgical standard treatment for isolated excessive axillary sweating is excision of the hair-bearing area of the axilla. This technique is associated with a risk of impaired wound healing, infections, wide scars and a risk of impairment in the movement of the arm (seldom). A new technique suction-curettage, much alike the liposuction technique, in which the dermis is curettage from a sub-dermal approach with a cutting and sucking devise, may be promising in regard to recovery and cosmetic appearance postoperatively, but the effect of the sweat production is not well known. This study compares liposuction vs. standard excision in individuals with isolated excessive isolated axillary sweating randomized to treatment with one of each technique in both axillas.

Interventions

Sponsors

Odense University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult individuals with primary axillary hyperhidrosis

Exclusion criteria

* Secondary axillary hyperhidrosis * Hidrosadenitis axillaris/inguinalis * Prior surgery * Iontophoresis or botox treatment 12 months prior * Known hypersensitivity to local analgetics (lidocaine)

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026